Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$825.6M
+13.6% from 2023
Prescriptions
1.3M
$644.19 per claim
Patients
339K
126,129 prescribers
Total spending, 2024
$825.8M
$2,434.85 per patient
Medicare prescription drug plans paid $825.6M for Tresiba Flextouch U-100 in 2024, for 1,281,627 prescriptions and refills to 339,062 patients (up 13.6% from 2023). The average cost per claim was $644.19.
Texas had the highest Medicare cost for Tresiba Flextouch U-100 in 2024: $78.3M for 117,359 claims, followed by Florida ($63.8M).
K. G Thampy, endocrinology in Saint Louis, MO, had the highest Medicare cost for Tresiba Flextouch U-100 in 2024: 671 claims costing $717K.
Tresiba Flextouch U-100 is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| K. G Thampy Saint Louis, MO | Endocrinology | 671 | 261 | $717K |
| Eugenio Angueira-Serrano Miami, FL | Endocrinology | 1,228 | 281 | $626K |
| Dewey J Bailey III |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 99,749 | 943,818 | 233,782 | $669.3M |
| 2023 | 106,311 | 999,903 | 258,359 | $726.8M |
| 2024 | 126,129 | 1,281,627 | 339,062 | $825.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 515 |
| 159 |
| $428K |
| Chadi Richeh Rancho Mirage, CA | Endocrinology | 380 | 153 | $421K |
| Joanna M Warren Jackson, MS | Nurse Practitioner | 663 | 160 | $408K |
| Maher Alesali White Hall, AR | Endocrinology | 543 | 124 | $387K |
| Brian E Burtch Willoughby, OH | Endocrinology | 368 | 134 | $374K |
| Malapuram Vasudha Reddy Huntsville, AL | Endocrinology | 287 | 91 | $361K |
| Deborah S Coon Melbourne, FL | Nurse Practitioner | 562 | 188 | $332K |
| Jennifer M Lavare Sidney, NY | Nurse Practitioner | 303 | 98 | $324K |
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 375 | 119 | $314K |
| Kashif A Latif Bartlett, TN | Endocrinology | 430 | 148 | $309K |
| Vasdev Lohano Washington, IN | Endocrinology | 444 | 148 | $304K |
| Assem Houssein Lancaster, OH | Endocrinology | 335 | 107 | $302K |
| Marcel B Twahirwa Edinburg, TX | Endocrinology | 421 | 159 | $285K |
| Arelis M Madera Port Charlotte, FL | Endocrinology | 362 | 162 | $284K |
| Christopher P Bruno Collegeville, PA | Endocrinology | 314 | 91 | $283K |
| Syed A Hassan Harlingen, TX | Endocrinology | 316 | 115 | $280K |
| Mohammad T Ijaz Zanesville, OH | Endocrinology | 381 | 103 | $269K |
| Charla Yassine Wichita, KS | Certified Clinical Nurse Specialist | 415 | 115 | $268K |
| Kristyl J Woolsey Little Rock, AR | Nurse Practitioner | 345 | 92 | $264K |
| Andrew D Henry Tampa, FL | Endocrinology | 140 | 38 | $255K |
| Bennett T Baquet Lafayette, LA | Endocrinology | 372 | 99 | $254K |
| Kylee Wilkinson Rocky Mount, NC | Nurse Practitioner | 342 | 121 | $243K |
| Anastasios Manessis New York, NY | Endocrinology | 365 | 128 | $242K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 1,281,963 | $825.8M |